Schrodinger (NASDAQ:SDGR) Research Coverage Started at UBS Group

UBS Group started coverage on shares of Schrodinger (NASDAQ:SDGR) in a report issued on Wednesday morning, MarketBeat Ratings reports. The firm issued a hold rating and a $18.00 price objective on the stock.

Several other brokerages also recently weighed in on SDGR. Wall Street Zen upgraded Schrodinger from a “sell” rating to a “hold” rating in a research note on Saturday, October 25th. TD Cowen decreased their price target on Schrodinger from $33.00 to $24.00 and set a “buy” rating for the company in a research note on Thursday. KeyCorp dropped their price target on Schrodinger from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday. The Goldman Sachs Group started coverage on shares of Schrodinger in a report on Monday, September 29th. They set a “neutral” rating and a $19.00 price objective on the stock. Finally, Bank of America raised shares of Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price objective for the company in a research report on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Schrodinger has an average rating of “Hold” and an average price target of $24.33.

Schrodinger Stock Down 1.2%

NASDAQ SDGR opened at $18.39 on Wednesday. Schrodinger has a 52 week low of $15.99 and a 52 week high of $28.47. The company has a 50 day moving average price of $17.98 and a 200 day moving average price of $19.49. The firm has a market cap of $1.35 billion, a PE ratio of -7.63 and a beta of 1.54.

Schrodinger (NASDAQ:SDGR) last announced its earnings results on Wednesday, November 5th. The company reported ($0.45) earnings per share for the quarter, beating the consensus estimate of ($0.72) by $0.27. The company had revenue of $54.32 million during the quarter, compared to the consensus estimate of $50.51 million. Schrodinger had a negative net margin of 68.49% and a negative return on equity of 48.24%. Schrodinger’s revenue was up 53.9% compared to the same quarter last year. During the same period last year, the firm earned ($0.87) earnings per share. On average, equities research analysts anticipate that Schrodinger will post -2.37 earnings per share for the current fiscal year.

Insider Buying and Selling at Schrodinger

In other news, insider Margaret Dugan sold 1,395 shares of the firm’s stock in a transaction dated Thursday, October 16th. The stock was sold at an average price of $21.07, for a total value of $29,392.65. Following the completion of the transaction, the insider directly owned 24,574 shares in the company, valued at $517,774.18. This trade represents a 5.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 21.00% of the company’s stock.

Hedge Funds Weigh In On Schrodinger

Hedge funds and other institutional investors have recently bought and sold shares of the business. Farther Finance Advisors LLC lifted its stake in Schrodinger by 347.4% during the 2nd quarter. Farther Finance Advisors LLC now owns 1,284 shares of the company’s stock valued at $26,000 after acquiring an additional 997 shares during the period. Bayforest Capital Ltd purchased a new position in shares of Schrodinger during the second quarter worth $30,000. Aster Capital Management DIFC Ltd raised its holdings in shares of Schrodinger by 212.4% during the third quarter. Aster Capital Management DIFC Ltd now owns 1,943 shares of the company’s stock worth $39,000 after purchasing an additional 1,321 shares during the last quarter. State of Wyoming acquired a new position in Schrodinger during the second quarter valued at $39,000. Finally, SBI Securities Co. Ltd. boosted its holdings in Schrodinger by 110.4% in the third quarter. SBI Securities Co. Ltd. now owns 2,127 shares of the company’s stock valued at $43,000 after purchasing an additional 1,116 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Key Stories Impacting Schrodinger

Here are the key news stories impacting Schrodinger this week:

• Positive Sentiment: Schrödinger announced a partnership with Eli Lilly to integrate Lilly’s TuneLab AI drug‑discovery platform into Schrödinger’s LiveDesign enterprise informatics platform, making TuneLab a priority interface for participating biotech customers — this strengthens LiveDesign’s product value and could accelerate commercial deals or usage-based revenue. Business Wire
• Positive Sentiment: Media coverage highlights Lilly’s broader pact (including Revvity) to provide AI-driven drug‑discovery capabilities — public attention and third‑party ecosystem involvement can increase demand for Schrödinger’s software interfaces and partnerships. MSN
• Neutral Sentiment: TD Cowen reduced its price target from $33 to $24 but maintained a “buy” rating — this narrows analyst-implied upside while still signaling confidence in long‑term growth potential. TickerReport
• Neutral Sentiment: KeyCorp lowered its target from $28 to $25 and kept an “overweight” rating — another mixed signal: lower near‑term targets but continued positive stance on the business model. TickerReport
• Neutral Sentiment: Market commentary comparing Schrodinger with peers appears, but offers limited incremental near‑term impact; useful for relative valuation context. American Banking News
• Negative Sentiment: UBS initiated coverage with a “hold” and a $18 price target (below recent levels), which could exert downward pressure or limit buying interest until catalysts justify re‑rating. MSN

Schrodinger Company Profile

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.